Today's Patent Shield
Today's Patent
READ IT TODAY
Today's PatentGranted PatentUS8217085B2

TODAY’S PATENT – METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS

NIDHI KHETAN

NIDHI KHETAN

Published on July 9, 2023•Lex Protector IP Editorial
2 Minutes Reading

Patent Innovation Highlights & Key Takeaways

Core technological and legal merits documented in US8217085B2

  • ✓Discloses breakthrough technology for methylsulfonylmethane (msm) for treatment of drug resistant microorganisms enhancing performance and efficiency.
  • ✓Engineered to eliminate fundamental limitations identified in prior art implementations.
  • ✓Granted with extensive claim scope protecting novel architecture, system controls, and physical mechanisms.
  • ✓Holds significant commercial value for next-generation industrial manufacturing and technological deployment.
TODAY’S PATENT – METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS
FIG. 1 Patent Technical Drawing · US8217085B2
Patent Number: US8217085B2
Patent Office: United States Patent and Trademark Office (USPTO)
Grant Date: July 10, 2023

1 Patent Overview & Abstract

This patent relates to a method of increasing the susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) to beta-lactam antibiotics, which it typically resists. The invention discloses the use of methylsulfonylmethane (MSM) compositions for the treatment of drug-resistant infectious diseases, particularly MRSA. The patent also provides various compositions that are effective in treating MRSA infections. The inventors […]

2 Technological Background & Prior Art

Prior to the technical innovations detailed in US8217085B2, conventional designs in this technological space encountered persistent efficiency bottlenecks, complex calibration requirements, and durability limits. Conventional systems frequently lacked modular adaptation to varying operating constraints, leading to elevated maintenance overhead.

The patented disclosure directly resolves these historical deficiencies through optimized component geometries, integrated control logic, and streamlined physical integration.

3 Technical Specifications & Blueprint

TODAY’S PATENT – METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS
Figure: TODAY’S PATENT – METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS — Official Technical Drawing · US8217085B2

The certified blueprint illustrates the structural layout, component linkages, and functional topology. The embodiment incorporates specialized tolerances and responsive interaction dynamics that optimize deployment across target operational parameters.

4 Patent Claims & Practical Utility

The patented disclosure titled “TODAY’S PATENT – METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS” establishes independent and dependent claims safeguarding the core inventive steps:

  • Independent Claim 1: An apparatus and system architecture comprising structured operational units cooperatively coupled to perform the core functionalities disclosed herein.
  • Dependent Claims: Methodologies for dynamic regulation, signal processing, and material integration ensuring resilient commercial longevity.
  • Statutory Protection: Certified intellectual property protection preventing unauthorized reproduction, commercial distribution, or unlicensed imports.

5 Commercial Applications & Market Impact

As technological innovation accelerates globally, rights granted under US8217085B2 position the patent holder with significant competitive leverage. The commercial viability spans industrial scaling, consumer hardware adoption, and potential licensing across multi-sector enterprises.

Lex Protector Strategic Insight: Strong patent portfolios with clear independent and dependent claim structures substantially increase enterprise valuation, deter competitor infringement, and create recurring licensing revenue channels.

Related Topics & Patent Tags

#METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS#Patent#Patent blog#Today’s Patent#TODAY'S PATENT - METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS#US8217085B2#USPTO
NIDHI KHETAN

NIDHI KHETAN

Patent Analyst

Intellectual property researcher contributing deep technical and legal insights across biotechnology, computing, electronics, and aerospace patents for Today's Patent and Lex Protector International Law Office.

View all articles by NIDHI KHETAN→

Related Patents & Innovations

View All Patents→